A 1.0ml (100 unit) syringe usually has marks every 2 units, which is still adequate for most semaglutide dosing
Researchers Call for Urgent Follow-Up Studies The FDA reporting system has important limitations
Clinical trials show that people typically regain approximately two-thirds of lost weight within a year of stopping, without ongoing support
If you suspect your menstrual changes may be related to tirzepatide, you can report this as a potential side effect through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)
5 Here we summarized the complex mechanisms of GLP-1RAs and their latest advancements in treating various diseases, such as musculoskeletal inflammation, obesity, cardiovascular diseases, NAFLD, neurodegenerative diseases, and various cancers
Cover Image Credit: Dml5050 / 123RF.com (Licensed)